Increased prevalence of gestational diabetes mellitus in in vitro fertilization pregnancies inadvertently conceived during treatment with long-acting triptorelin acetate

Fertility and Sterility

Volumn 84, Issue 3, 2005, Pages 789-792

  Mayer, Amit ^a   Lunenfeld, Eitan ^a   Wiznitzer, Arnon ^a   Har Vardi, Iris ^a   Bentov, Yacov ^a   Levitas, Eliahu ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

GONADORELIN AGONIST; TRIPTORELIN; TRIPTORELIN ACETATE; UNCLASSIFIED DRUG;

ABORTION; ADULT; ARTICLE; CLINICAL ARTICLE; CONCEPTION; CONGENITAL MALFORMATION; CONTROLLED STUDY; FEMALE; FERTILIZATION IN VITRO; HUMAN; LONG TERM CARE; LUTEAL PHASE; PREGNANCY DIABETES MELLITUS; PREVALENCE; PRIORITY JOURNAL;

ADULT; DELAYED-ACTION PREPARATIONS; DIABETES, GESTATIONAL; FEMALE; FERTILIZATION IN VITRO; HUMANS; PREGNANCY; PREGNANCY OUTCOME; PREVALENCE; TRIPTORELIN;

EID: 24944485103     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2005.03.058     Document Type: Article

References (32)

1. J. Smitz, P. Devroey, M. Camus, I. Khan, C. Staessen, L. Van Waesberghe Addition of Buserelin to human menopausal gonadotrophins in patients with failed stimulations for IVF or GIFT Hum Reprod 3 1988 35 38
2. S. Neveu, B. Hedon, J. Bringer, J.M. Chinchole, F. Amal, C. Humeau Ovarian stimulation by a combination of a gonadotropin-releasing hormone agonist and gonadotropins for in vitro fertilization Fertil Steril 47 1987 639 643
3. V. Insler, G. Potashnik, E. Lunenfeld, I. Meizner, J. Levy The combined suppression/stimulation therapy in IVF-ET programmes expectations and facts Hum Reprod 4 Suppl 1989 47 51
4. E.G. Hughes, D.M. Federkow, S. Daya, M.A. Sagle, P. Van de Koppel, J.A. Collins The routine use of gonadotropin-releasing hormone agonists prior to in vitro fertilization and gamete intrafallopian transfer a meta-analysis of randomized controlled trials Fertil Steril 58 1992 888 896
5. J. Balasch, J. Martinez, I. Jove, L. Cabre, B. Cololeu, P.N. Barri Inadvertent gonadotrophin-releasing hormone agonist (GnRHa) administration in the luteal phase may improve fecundity in in-vitro fertilization patients Hum Reprod 8 1993 1148 1151
6. H.M. Fraser, J. Sandow Suppression of follicular maturation by infusion of a luteinizing hormone-releasing hormone agonist starting during the late luteal phase in the stumptailed macaque monkey J Clin Endocrinol Metab 60 1985 579 584
7. M. Filiconi, C. Flagnigni Risks of GnRH agonist administration in early pregnancy in ovulation induction. Update 98 1997 Pantheon New York
8. U.S. Food and Drug Administration Labeling and prescription drug advertising content and format for labeling for human prescription drugs Fed Regist 44 1980 37434 37467
9. G.B. Wilshire, A.M. Emmi, C.C. Gagliardi, G. Weiss Gonadotropin-releasing hormone agonist administration in early human pregnancy is associated with normal outcomes Fertil Steril 60 1993 980 983
10. D.C. Young, M.C. Snabes, A.N. Poindexter 3rd GnRH agonist exposure during the first trimester of pregnancy Obstet Gynecol 81 1993 587 589
11. A.T. Abu-Heija, R. Fleming, R.W. Yates, J.R. Coutts Pregnancy outcome following exposure to gonadotrophin-releasing hormone analogue during early pregnancy comparisons in patients with normal or elevated luteinizing hormone Hum Reprod 10 1995 3317 3319
12. E. Elefant, B. Biour, J. Blumberg-Tick, C. Roux, F. Thomas Administration of a gonadotropin-releasing hormone agonist during pregnancy follow-up of 28 pregnancies exposed to triptorelin Fertil Steril 63 1995 1111 1113
13. D. Chardonnens, K. Sylvan, D. Walker, P. Bischof, D. Sakkas, A. Campana Triptorelin acetate administration in early pregnancy case reports and review of the literature Eur J Obstet Gynecol Reprod Biol 80 1998 143 149
14. E. Lahat, A. Raziel, S. Friedler, M. Schieber-Kazir, R. Ron-El Long-term follow-up of children born after inadvertent administration of a gonadotrophin-releasing hormone agonist in early pregnancy Hum Reprod 14 1999 2656 2660
15. J.B. O'Sullivan, C.M. Mahan, D. Charles, R.V. Androw Screening criteria for high-risk gestational diabetic patients Am J Obstet Gynecol 116 1973 895 900
16. P. White Pregnancy complicating diabetes Am J Med 7 1949 609
17. L. Anttila, K. Karjala, R.A. Penttila, K. Ruutiainen, U. Ekblad Polycystic ovaries in women with gestational diabetes Obstet Gynecol 92 1998 13 16
18. E. Kousta, E. Cela, N. Lawrence, A. Penny, B. Millauer, D. White The prevalence of polycystic ovaries in women with a history of gestational diabetes Clin Endocrinol 53 2000 501 507
19. R.M. Koivunen, J. Juutinen, I. Vauhkonen, L.C. Morin-Papunen, A. Ruokonen, J.S. Tapanainen Metabolic and steroidogenic alterations related to increased frequency of polycystic ovaries in women with a history of gestational diabetes J Clin Endocrinol Metab 86 2001 2591 2599
20. J.A. Martin, B.E. Hamilton, S.J. Ventura, F. Menacker, M.M. Park, P.D. Sutton Births final data for 2001 Natl Vital Stati Rep 51 2002 1 102
21. E. Maman, E. Lunenfeld, A. Levy, H. Vardi, G. Potashnik Obstetric outcome of singleton pregnancies conceived by in vitro fertilization and ovulation induction compared with those conceived spontaneously Fertil Steril 70 1998 240 245
22. E. Porcu, L. Dal Prato, R. Seracchioli, R. Fabbri, M. Longhi, C. Flamigni Comparison between depot and standard release triptoreline in in vitro fertilization pituitary sensitivity, luteal function, pregnancy outcome, and perinatal results Fertil Steril 62 1994 126 132
23. A. Lanzone, A.M. Fulghesu, C.L. Andreani, R. Apa, A. Fortini, A. Caruso Insulin secretion in polycystic ovarian disease effect of ovarian suppression by GnRH agonist Hum Reprod 5 1990 143 149
24. A. Dunaif, G. Green, W. Futterweit, A. Dobrjansky Suppression of hyperandrogenism does not improve peripheral or hepatic insulin resistance in the polycystic ovary syndrome J Clin Endocrinol Metab 70 1990 699 704
25. S. Chauhan, K. Collins, M. Kruger, M.P. Diamond Effect of gonadotropin-releasing hormone hypogonadism on insulin action as assessed by hyperglycemic clamp studies in men Fertil Steril 81 2004 1092 1098
26. K. Demyttenaere, P. Nijs, G. Evers-Kiebooms, P.R. Koninckx Personality characteristics, psychoendocrinological stress and outcome of IVF depend upon the etiology of infertility Gynecol Endocrinol 8 1994 233 240
27. T.A. Bramley, G.S. Menzies, D.T. Baird Specific binding of gonadotrophin-releasing hormone and an agonist to human corpus luteum homogenates characterization, properties, and luteal phase levels J Clin Endocrinol Metab 61 1985 834 841
28. R.W. Tureck, L. Mastroianni Jr, L. Blasco, J.F. Strauss 3rd Inhibition of human granulosa cell progesterone secretion by a gonadotropin-releasing hormone agonist J Clin Endocrinol Metab 54 1982 1078 1080
29. A.J. Wilcox, C.R. Weinberg, J.F. O'Connor, D.D. Baird, J.P. Schlatterer, R.E. Canfield Incidence of early loss of pregnancy N Engl J Med 319 1988 189 194
30. Z. Shoham, A. Zosmer, V. Insler Early miscarriage and fetal malformations after induction of ovulation (by clomiphene citrate and/or human menotropins), in vitro fertilization, and gamete intrafallopian transfer Fertil Steril 55 1991 1 11
31. T.H. Shepard Human teratogenicity Adv Pediatr 33 1986 225 268
32. T.E. Goldner, H.W. Lawson, Z. Xia, H.K. Atrash Surveillance for ectopic pregnancy - United States, 1970-1989 MMWR CDC Surveill Summ 42 1993 73 85